Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 6 M18 M23 M9 M22 M25 M 79 M Research & development —————— — Operating income 579 M533 M757 M904 M605 M1.56 B 3.83 B Non-Operating Income, Total -69 M————— — Interest expense, net of interest capitalized 3 M31 M20 M33 M37 M53 M 143 M Non-Operating Income, excl. Interest Expenses -3 M————— — Unusual income/expense -69 M————— — Pretax income 582 M659 M770 M914 M696 M1.33 B 3.71 B Equity in earnings 58 M181 M110 M53 M70 M199 M 432 M Taxes 75 M75 M78 M299 M110 M162 M 649 M Non-controlling/minority interest 48 M54 M127 M140 M69 M201 M 537 M After tax other income/expense -71 M-26 M-81 M-51 M39 M2 M -91 M Net income before discontinued operations 507 M584 M692 M615 M586 M1.17 B 3.06 B Discontinued operations —————— — Net income 507 M584 M692 M615 M586 M1.17 B 3.06 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 581 M620 M724 M560 M617 M904 M 2.81 B Basic earnings per share (Basic EPS) 0.360.380.450.350.390.56 1.75 Diluted earnings per share (Diluted EPS) 0.360.380.440.340.380.56 1.72 Average basic shares outstanding 1.61 B1.61 B1.61 B1.61 B1.61 B1.6 B — Diluted shares outstanding 1.63 B1.63 B1.63 B1.63 B1.62 B1.61 B — EBITDA 582 M544 M773 M914 M618 M1.11 B 3.41 B EBIT 579 M533 M757 M904 M605 M1.09 B 3.36 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 3 M11 M16 M10 M13 M13 M 52 M